---
title: "Morgan Stanley Sticks to Their Buy Rating for Telix Pharmaceuticals (TLPPF)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298975341.md"
description: "Morgan Stanley analyst David Bailey maintained a Buy rating on Telix Pharmaceuticals (TLPPF) with a price target of A$23.90, citing his strong track record in the Healthcare sector. This follows Bell Potter's recent decision to also maintain a Buy rating on the stock, setting their price target at A$19.00."
datetime: "2026-09-15T00:05:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298975341.md)
  - [en](https://longbridge.com/en/news/298975341.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298975341.md)
generator: "portal-rs"
---

# Morgan Stanley Sticks to Their Buy Rating for Telix Pharmaceuticals (TLPPF)

In a report released today, David Bailey from Morgan Stanley maintained a Buy rating on Telix Pharmaceuticals, with a price target of A$23.90.

Bailey covers the Healthcare sector, focusing on stocks such as Integral Diagnostics Ltd., Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh, and CSL. According to TipRanks, Bailey has an average return of 8.9% and a 50.42% success rate on recommended stocks. 

In a report released yesterday, Bell Potter also maintained a Buy rating on the stock with a A$19.00 price target.

### Related Stocks

- [TLX.US](https://longbridge.com/en/quote/TLX.US.md)
- [TLX.AU](https://longbridge.com/en/quote/TLX.AU.md)
- [MS.US](https://longbridge.com/en/quote/MS.US.md)
- [IDX.AU](https://longbridge.com/en/quote/IDX.AU.md)
- [RMD.AU](https://longbridge.com/en/quote/RMD.AU.md)
- [MS-O.US](https://longbridge.com/en/quote/MS-O.US.md)
- [MS-Q.US](https://longbridge.com/en/quote/MS-Q.US.md)
- [MS-E.US](https://longbridge.com/en/quote/MS-E.US.md)
- [MS-I.US](https://longbridge.com/en/quote/MS-I.US.md)
- [MS-L.US](https://longbridge.com/en/quote/MS-L.US.md)
- [MS-P.US](https://longbridge.com/en/quote/MS-P.US.md)
- [MS-A.US](https://longbridge.com/en/quote/MS-A.US.md)
- [MS-F.US](https://longbridge.com/en/quote/MS-F.US.md)
- [MS-K.US](https://longbridge.com/en/quote/MS-K.US.md)
- [RMD.US](https://longbridge.com/en/quote/RMD.US.md)

## Related News & Research

- [Telix Pharmaceuticals reports Q3 results](https://longbridge.com/en/news/302495942.md)
- [Telix Pharmaceuticals Limited (TLX) Issues Q3 Update, Reaffirms 2026 PM Growth Target](https://longbridge.com/en/news/302474055.md)
- [Canaccord Genuity Keeps Their Buy Rating on Telix Pharmaceuticals (TLPPF)](https://longbridge.com/en/news/300886940.md)
- [Morgan Stanley Remains a Buy on Telix Pharmaceuticals (TLPPF)](https://longbridge.com/en/news/298377353.md)
- [Bell Potter Sticks to Its Buy Rating for Telix Pharmaceuticals (TLPPF)](https://longbridge.com/en/news/299580593.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**